dc.contributor.author |
Kaya, Kürşat |
|
dc.contributor.author |
Çiftçi, Osman |
|
dc.contributor.author |
Çetin, Aslı Çetin |
|
dc.contributor.author |
Tecellioglu, Mehmet |
|
dc.contributor.author |
Başak, Neşe |
|
dc.date.accessioned |
2022-12-14T06:18:39Z |
|
dc.date.available |
2022-12-14T06:18:39Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
0102-8650 |
|
dc.identifier.uri |
http://dspace.adiyaman.edu.tr:8080/xmlui/handle/20.500.12414/4042 |
|
dc.description.abstract |
PURPOSE: To investigate the protective effect of Bg on cisplatin (CP)-induced neurotoxicity in rats.
METHODS: Twenty eight rats were randomly distributed into four groups. The first group was kept as a control. In the second group, CP was given at the single dose of 7 mg/kg intraperitoneally. In the third group, beta g was orally administered at the dose of 50 mg/kg/day for 14 days. In the fourth group, CP and beta g were given together at the same doses.
RESULTS: CP treatment caused significant oxidative damage via induction of lipid peroxidation and reductions antioxidant defense system potency in the brain tissue. In addition, histopathological damage increased with CP treatment. On the other hand, beta g treatment largely prevented oxidative and histopathological negative effects of CP.
CONCLUSIONS: Cisplatin has severe neurotoxic effects in rats and ag supplementation has significant beneficial effects against CP toxicity depending on its antioxidant properties. Thus, it appears that Ag might be useful against CP toxicity in patients with cancer in terms of nervous system. |
tr |
dc.language.iso |
en |
tr |
dc.publisher |
Acta Cırurgıca Brasıleıra |
tr |
dc.subject |
Cisplatin |
tr |
dc.subject |
Beta-Glucans |
tr |
dc.subject |
Nervous System |
tr |
dc.subject |
Oxidative stress |
tr |
dc.subject |
Rats |
tr |
dc.title |
Beneficial effects of beta-glucan against cisplatin side effects on the nervous system in rats |
tr |
dc.type |
Article |
tr |
dc.contributor.authorID |
0000-0002-6353-7791 |
tr |
dc.contributor.authorID |
0000-0001-5755-3560 |
tr |
dc.contributor.authorID |
0000-0003-3902-3210 |
tr |
dc.contributor.authorID |
0000-0002-8381-9630 |
tr |
dc.contributor.authorID |
0000-0001-5566-8321 |
tr |
dc.contributor.department |
Adiyaman Univ, Fac Pharm, Dept Biochem, |
tr |
dc.contributor.department |
Inonu Univ, Dept Pharmacol, Fac Med |
tr |
dc.contributor.department |
Inonu Univ, Dept Histol & Embryol, Fac Med, |
tr |
dc.contributor.department |
Inonu Univ, Dept Neurol, Fac Med, |
tr |
dc.contributor.department |
Inonu Univ, Dept Pharmaceut Toxicol, Fac Pharm |
tr |
dc.contributor.department |
Inonu Univ, Expt Anim Unit |
tr |
dc.contributor.department |
Inonu Univ, Neurosci Lab, |
tr |
dc.identifier.endpage |
205 |
tr |
dc.identifier.issue |
3 |
tr |
dc.identifier.startpage |
198 |
tr |
dc.identifier.volume |
31 |
tr |
dc.source.title |
Acta Cırurgıca Brasıleıra |
tr |